These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 16513609)
1. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609 [TBL] [Abstract][Full Text] [Related]
2. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734 [TBL] [Abstract][Full Text] [Related]
3. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948 [TBL] [Abstract][Full Text] [Related]
4. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871 [TBL] [Abstract][Full Text] [Related]
5. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT. Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468 [TBL] [Abstract][Full Text] [Related]
6. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma. Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668 [TBL] [Abstract][Full Text] [Related]
7. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Rajendran JG; Wilson DC; Conrad EU; Peterson LM; Bruckner JD; Rasey JS; Chin LK; Hofstrand PD; Grierson JR; Eary JF; Krohn KA Eur J Nucl Med Mol Imaging; 2003 May; 30(5):695-704. PubMed ID: 12632200 [TBL] [Abstract][Full Text] [Related]
8. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor. Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745 [TBL] [Abstract][Full Text] [Related]
9. Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer. Segard T; Robins PD; Yusoff IF; Ee H; Morandeau L; Campbell EM; Francis RJ Clin Nucl Med; 2013 Jan; 38(1):1-6. PubMed ID: 23242037 [TBL] [Abstract][Full Text] [Related]
10. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054 [TBL] [Abstract][Full Text] [Related]
12. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Thorwarth D; Eschmann SM; Holzner F; Paulsen F; Alber M Radiother Oncol; 2006 Aug; 80(2):151-6. PubMed ID: 16920211 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. Yamamoto Y; Maeda Y; Kawai N; Kudomi N; Aga F; Ono Y; Nishiyama Y Nucl Med Commun; 2012 Jun; 33(6):621-5. PubMed ID: 22422099 [TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting. Mammar H; Kerrou K; Nataf V; Pontvert D; Clemenceau S; Lot G; George B; Polivka M; Mokhtari K; Ferrand R; Feuvret L; Habrand JL; Pouysségur J; Mazure N; Talbot JN Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):681-7. PubMed ID: 22391104 [TBL] [Abstract][Full Text] [Related]
15. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy. Okamoto S; Shiga T; Yasuda K; Watanabe S; Hirata K; Nishijima KI; Magota K; Kasai K; Onimaru R; Tuchiya K; Kuge Y; Shirato H; Tamaki N Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2147-2154. PubMed ID: 27251644 [TBL] [Abstract][Full Text] [Related]
16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
18. pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Gagel B; Reinartz P; Dimartino E; Zimny M; Pinkawa M; Maneschi P; Stanzel S; Hamacher K; Coenen HH; Westhofen M; Büll U; Eble MJ Strahlenther Onkol; 2004 Oct; 180(10):616-22. PubMed ID: 15480509 [TBL] [Abstract][Full Text] [Related]
19. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment. Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194 [TBL] [Abstract][Full Text] [Related]
20. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study. Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]